WebApr 2, 2024 · Objectives: This meta-analysis was designed to systematically evaluate whether autologous cytokine-induced killer cells (CIK) or dendritic cells and cytokine-induced killer cells (DC-CIK) immunotherapy combined with chemotherapy can improve the therapeutic effect and safety of chemotherapy in esophageal cancer (EC).. Materials … WebSep 1, 2024 · CIK cell therapy can be an effective adjuvant instrument of the routine anti-tumor treatment: Cui et al. 121 (7 RCC) Tumor lysate-pulsed DCs + auto-CIKs: …
CIK as therapeutic agents against tumors - ScienceDirect
WebJul 5, 2024 · IntroductionProgrammed cell death-1 (PD-1) inhibition therapy has changed the treatment paradigm of metastatic renal cell carcinoma (MRCC) and non-small cell lung cancer (NSCLC). However, attempts to use the drug as a single agent have achieved only limited clinical success. To further enhance the clinical benefits of monotherapy, … WebAug 21, 2014 · The first studies in the literature already demonstrated the high cytotoxic potential of CIK cells against transformed hematopoietic cells in in vitro and animal tumor models [2,3]. Very recently, an increasing number of clinical trials have reported that the adoptive CIK cell transfer revealed considerable antitumor efficacy and led to both ... イヌガヤ 花言葉
Targeting prostate cancer stem-like cells by an …
WebJan 25, 2024 · We can envision future clinical studies with CIK cells against minimal tumor diseases, perhaps with innovative schedules of administration, such as higher and more … WebJul 6, 2024 · Cytokine-induced killer (CIK) cells are a heterogeneous population of effector CD3+CD56+ natural killer T cells, which can be easily expanded in vitro from peripheral blood mononuclear cells. CIK cells … WebJan 3, 2024 · Recently, immune checkpoint inhibitors (ICIs) therapy has become a promising therapeutic strategy with encouraging therapeutic outcomes due to their durable anti-tumor effects. Though, tumor inherent or acquired resistance to ICIs accompanied with treatment-related toxicities hamper their clinical utility. Overall, about 60–70% of patients … イヌガヤ科